Blanchard Cheryl R

Blanchard Cheryl R is listed in filings as Director at Xilio Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 16, 2026, including 21 public disclosures. Recent filings connect the profile to Xilio Therapeutics, Inc. (XLO), Anika Therapeutics, Inc. (ANIK), and Vigil Neuroscience, Inc. (VIGL). The current snapshot covers public activity from Mar 11, 2025 to Apr 16, 2026. Reported amounts are shown as $84.0K to $209.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.